The U.S. Nuclear Regulatory Commission (NRC) has agreed to issue a construction permit to Shine Medical Technologies for a medical isotope manufacturing facility to be built in Janesville, WI.
The permit is the result of more than four years of effort by both Shine Medical and the NRC, and it's the first such permit issued since the 1960s, according to the company.
The new facility will be approximately 57,000 sq ft and will produce molybdenum-99, which decays into the diagnostic imaging agent technetium-99m. Technetium-99m is used in more than 40 million medical imaging procedures each year, primarily in stress tests to diagnose heart disease and in bone scans to stage cancer, Shine said.
